Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$270.95M-10.31%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Kimberly A. Rivers
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5,000
- Beta
- 1.76
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 0.34
Financials
TRLV has only 5 quarterly periods on file — the charts below show the full history available.
Revenue
$270.95M-10.3%Net Income
$-406.06MEBITDA
$-370.64M-476.5%Free Cash Flow
$32.10M-53.8%EPS (diluted)
$-2.10Shares Outstanding (diluted)
192.71M+0.8%Operating Expenses
$101.77MCash & Debt
$325.42MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.18B | $-116.38M | $-0.61 |
Valuation
TRLVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (3)
- Newsprnewswire.com·8d ago·Negative
…rida and Texas Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
View source ↗ - Newsseekingalpha.com·24d ago·Positive
…% rally. Rescheduling of medicinal cannabis to Schedule III eliminates punitive tax burdens, boosts cash flows, and enables greater R&D and financing flexibility for TRLV. TRLV is well-positioned for growth through Florida consolidation, expansion into Texas and Alabama, and potential upside from a $583M tax liability reversal.
View source ↗ - Newsprnewswire.com·55d ago·Negative
Trulieve Completes Redomicile from British Columbia to Delaware TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the completion of its previously announced plan to redomicile Trulieve Cannabis Corp. from British Columbia, Canada to Delaware, United States.
View source ↗
Earnings
Fri, Nov 6(in 4 weeks)
Consensus estimate $0.09 per share
Typical surprise -65.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-2.11 vs $0.06miss
- Thu, May 7$0.01 vs $-0.01beat
- Thu, Feb 26$-0.22 vs $-0.07miss
- Wed, Nov 5$-0.14 vs $-0.08miss
- Wed, Aug 6$-0.07 vs $-0.06miss
- Wed, May 7$-0.17 vs $-0.07miss
Estimates and results for TRLV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by TRLV officers and directors.
- Bought
- —
- Sold
- $14.7m
0 trades
7 trades
- Rivers Kim A.sold
- Rivers Kim A.sold
- Rivers Kim A.sold
- Rivers Kim A.sold
- Rivers Kim A.sold
- Rivers Kim A.sold
- Rivers Kim A.sold
Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in TRLV.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.